Young Ae Lee

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Neurotech Pharmaceuticals Co., Ltd., Neurotech Co., Ltd., Pharmabcine Inc.. Active years: 2003-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Ae Lee. Retrieved from https://idiyas.com/inventor/young-ae-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 80.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Kyunggi-do, KR (2003)
Suwon-si, KR (2003 - 2014)
Daejeon, KR (2018)

Company Filing History:

4 out of 8

Neurotech Pharmaceuticals Co., Ltd.

Years Active: 2003-2018

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10155817 - Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same (2018-12-18),

2. 9963512 - Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same (2018-05-08),

3. 8686185 - Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts (2014-04-01),

4. 8211878 - Method for reducing neuronal death in nervous system injuries resulting from amyotrophic lateral sclerosis (2012-07-03),

5. 8211877 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system (2012-07-03),

6. 7750045 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system (2010-07-06),

7. 7319160 - Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same (2008-01-15),

8. 6964982 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system (2005-11-15),

9. 6573402 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system (2003-06-03),

10. 6521640 - Method for interviewing neuronal death using sulfasalazine (2003-02-18),

Title: Innovator Spotlight: Young Ae Lee - Pioneering Neuroprotective Solutions

Introduction:

Young Ae Lee, a distinguished inventor based in Suwon-si, Korea, has made significant contributions to the field of neuroprotection with a notable portfolio of 8 patents. His groundbreaking work focuses on the development of innovative methods for preventing neurodegeneration in acute and chronic injuries within the central nervous system.

Latest Patents:

1. Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts: In this patent, Young Ae Lee presents an efficient method for mass-producing specific chemical compounds, such as 2-hydroxy-5-[2-(4-trifluoromethylphenyl)ethylamino]benzoic acid, or its salt.

2. Compounds, compositions, and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system: This patent outlines the synthesis of 5-benzylamino salicylic acid (BAS) and its derivatives, which have shown promise in protecting cortical neurons from various toxic insults.

Career Highlights:

Young Ae Lee has garnered experience and expertise through his tenure at esteemed companies such as Neurotech Pharmaceuticals Co., Ltd. and Neurotech Co., Ltd. His innovative approaches have paved the way for advanced treatments and preventative measures in the realm of neurodegenerative diseases and neuronal death.

Collaborations:

Throughout his career, Young Ae Lee has collaborated with esteemed colleagues such as Byoung Joo Gwag and Bo Rum Ryu. Together, they have contributed to the development of cutting-edge solutions aimed at addressing critical challenges in neuroprotection and neurological diseases.

Conclusion:

In conclusion, Young Ae Lee stands as a trailblazer in the field of neuroprotection, with a robust patent portfolio and a legacy of impactful innovations. His dedication to advancing treatments for neurodegenerative diseases underscores his commitment to improving the quality of life for individuals affected by such conditions. Young Ae Lee's contributions continue to inspire and drive progress in the field of neuroscience and neuroprotection.

Profile summary based on public USPTO records.